Treatment with recombinant alfa-2b-interferon in a patient with advanced B-
CLL resulting in complete remission of skin lesions after one month therapy
is reported in this paper. Interferon was administered subcutaneously thre
e times weekly. Six months later while the treatment continued, the disease
remained stable.